Good evening :)
$
₹
Cosmos Health Inc.

Cosmos Health Inc.

COSM

NASDAQ
Asset Logo

Cosmos Health Inc.

COSM

NASDAQ
$0.2911.47% (-0.03)
$
₹
$0.2911.47% (-0.03)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Distribution

Micro Cap

With a market cap of $33.0M the stock is ranked 5276

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.46
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.65
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-33.08%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 1 analyst's reports

Buy
1 analyst
Hold
0 analyst
Sell
0 analyst

Price Upside

+800.49%

Earnings Growth

+88.41%

Rev. Growth

+30.85%

See Detailed Forecast

Company Profile

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
McKesson Corporation
MCK
McKesson Corporation
P/E Ratio
27.58
27.58
1Y Return
26.97%
26.97%
Buy Reco %
81.25
81.25
Cencora Inc.
COR
Cencora Inc.
P/E Ratio
25.28
25.28
1Y Return
0.16%
0.16%
Buy Reco %
71.42
71.42
Cardinal Health Inc
CAH
Cardinal Health Inc
P/E Ratio
34.97
34.97
1Y Return
33.1%
33.1%
Buy Reco %
82.35
82.35
Henry Schein Inc
HSIC
Henry Schein Inc
P/E Ratio
24.17
24.17
1Y Return
22.53%
22.53%
Buy Reco %
50.00
50.00
Adapthealth Corp
AHCO
Adapthealth Corp
P/E Ratio
—
—
1Y Return
29.3%
29.3%
Buy Reco %
100.00
100.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 800.49% growth, versus a trailing 3-year CAGR of -32.60%.

2026
Current$0.33Baseline
Analyst Target - 1 year
Target$2.95+800.49%

All values in $

202220232024202520262027$1.48$2.66$3.84Target+800.49%
2026
Current$0.33Baseline
Analyst Target - 1 year
Target$2.95+800.49%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 30.85% growth, versus a trailing 3-year CAGR of 9.04%.

2025
Current$65.27Baseline
Forecast for Dec 2026
High$90.01+37.91%
Average$85.40+30.85%
Low$80.8+23.79%

All values in $ Million

20212022202320242025202656.2350.3453.3754.4265.27Low+23.79%Average+30.85%High+37.91%
2025
Current$65.27Baseline
Forecast for Dec 2026
High$90.01+37.91%
Average$85.40+30.85%
Low$80.8+23.79%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$-1.29Baseline
Forecast for Dec 2026
High$-0.08+93.82%
Average$-0.15+88.41%
Low$-0.22+83%

All values in $

20212022202320252026-13.59-5.35-9.57-1.29Low+83%Average+88.41%High+93.82%
2025
Current$-1.29Baseline
Forecast for Dec 2026
High$-0.08+93.82%
Average$-0.15+88.41%
Low$-0.22+83%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

17.1
-5.3
19.7
-10.1
17.9
-2.8
18.9
-6
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue14.5813.2012.4114.2213.7114.7417.1119.7017.9218.98
Net Income-1.86-2.59-2.18-9.54-0.81-2.82-5.35-10.14-2.80-6.08
Net Profit Margin-12.79%-19.61%-17.58%-67.09%-5.96%-19.17%-31.28%-51.49%-15.64%-32.05%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Distribution

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Cosmos Health Inc. -1.460
McKesson Corporation27.585.041.87
Cencora Inc.25.2821.290.71
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare COSM with any stock or ETF
Compare COSM with any stock or ETF
Comparing from
COSM
MCK
COR
Loading...

Frequently asked questions

  1. Cosmos Health Inc. (COSM) share price today is $0.28 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $0.31 and a day low of $0.28.

  2. Cosmos Health Inc. stock trades on NASDAQ under the ticker symbol COSM.

  3. Cosmos Health Inc.'s market capitalization is $32.96M as of November 6, 2026 at 2:29 AM IST.

  4. Cosmos Health Inc.'s price-to-earnings (P/E) ratio is N/A as of November 6, 2026.

  5. Cosmos Health Inc.'s price-to-book (P/B) ratio is 1.46 as of November 6, 2026.

  6. Yes, You can buy Cosmos Health Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Cosmos Health Inc. shares in three steps: 1. Search Cosmos Health Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Cosmos Health Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Cosmos Health Inc. (COSM) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 34.4827 shares at the current price of $0.28.

Loading...